References for Breast Cancer Oncologist

• Beslija S, Bonneterre J, Burstein HJ, Cocquyt V, Gnant M, Heinemann V. (et al). (2009) Central European Cooperative Oncology Group (CECOG).Third consensus on medical treatment of metastatic breast cancer. Ann Oncol. 2009 Nov;20(11):1771-85. http://www.cecog.org/publications/metastatic-breast-cancer/
• Clemons M, Hamilton T, Mansi J, Lockwood G, Goss P. (2003) Management of recurrent locoregional breast cancer: oncologist survey.Breast. 2003 Oct;12(5):328-37. https://www.ncbi.nlm.nih.gov/pubmed/14659148
• Laird BJA, Fallon MT. (2009) Palliative Care in the Elderly Breast Cancer Patient. Clinical Oncology ( March 2009) Vol. 21, 2., p131-139. http://www.clinicaloncologyonline.net/article/S0936-6555(08)00453-6/abstract
• McArthur HL. (2007) Adjuvant chemotherapy for early-stage breast cancer. Hematol Oncol Clin North Am – 01-(APR-2007) 21(2): 207-22
• Nardini C. (2014) The ethics of clinical trials Ecancermedicalscience. 2014; 8: 387. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894239/
• Perez EA, Moreno-Aspitia A. Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane. Mayo Clinic Proceedings June 2009 vol. 84 no. 6 533-545 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688627/
• Perez EA, Moreno-Aspitia A. Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane. Mayo Clinic Proceedings June 2009 vol. 84 no. 6 533-545 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688627/
• Shah S, Dowell J, Greene S. (2006) Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting. Ann Pharmacother. 2006 Sep;40(9):1527-33. Epub 2006 Aug 1. http://journals.sagepub.com/doi/abs/10.1345/aph.1H162?journalCode=aopd
• Winer E, Piccart M, Krop I. (2010) Expert Perspectives on Breast Cancer — Highlights From the 35th Annual Congress of the European Society of Medical Oncology.